| Kabra Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524322 |
NSE Symbol : - |
P/E(TTM) : 59.44 |
|
ISIN Demat : INE323K01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.50 |
|
Book Value(₹) : 10.96 |
Market Cap(₹Cr) : 70.46 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 19.76 | 7.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 19.76 | 7.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.18 | 0.02 | 0.64 | 0.00 | 0.00 | 0.00 |
| Total Income | 19.94 | 7.17 | 0.64 | 0.00 | 0.00 | 0.00 |
| Total Expenditure | 17.73 | 7.66 | 0.24 | 0.53 | 0.40 | 0.55 |
| PBIDT | 2.22 | -0.50 | 0.40 | -0.53 | -0.40 | -0.55 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 2.22 | -0.50 | 0.40 | -0.53 | -0.40 | -0.55 |
| Depreciation | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Tax | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.84 | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.84 | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| EPS (Unit Curr.) | 0.77 | -0.21 | 0.21 | -0.53 | -0.39 | -1.24 |
| EPS (Adj) (Unit Curr.) | 0.77 | -0.21 | 0.21 | -0.53 | -0.39 | -1.24 |
| Calculated EPS (Unit Curr.) | 0.77 | -0.21 | 0.17 | -0.53 | -0.39 | -1.24 |
| Calculated EPS (Adj) (Unit Curr.) | 0.77 | -0.21 | 0.17 | -0.53 | -0.39 | -1.24 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.10 | -0.84 | 0.66 | -2.13 | -1.57 | -4.97 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.10 | -0.84 | 0.66 | -2.13 | -1.57 | -4.97 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 23.71 | 23.71 | 23.71 | 10.08 | 10.08 | 4.39 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 11.23 | -6.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 11.23 | -6.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 9.31 | -6.99 | 0.00 | 0.00 | 0.00 | 0.00 |